Myeloma Foundation to Host Seminar in Short Hills

The International Myeloma Foundation (IMF), an organization dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure, will hold its next Patient & Family Seminar on Oct. 10 and 11 in Short Hills.

Led by Dr. Brian Durie, Chairman and and Co-Founder of the IMF and also featuring the Mayo Clinic’s Dr. Robert Kyle, John Theurer Cancer Center’s Dr. David Vesole, Columbia University’s Dr. Suzanne Lentzsch, Binding Site’s Dr. Naveen Bangia, Ann Mc Neill, RN, MSN, APN, OCN, and patient advocate Mike Katz, this two-day workshop at the Hilton Short Hills will include presentations on the latest news and developments in myeloma research and therapies, as well as opportunities for patient-doctor interactions.

“Since 1993, the IMF has been empowering patients through educational seminars, and these patient and family seminars help us broaden our reach to patients all across the country,” said Susie Novis, IMF President and Co-Founder. “The events are designed to emphasize education, advocacy, and support, which provides invaluable information to the myeloma community.”

The IMF’s Patient & Family Seminars feature a half-day meeting on Fridays and a full-day, interactive seminar on Saturdays with world-renowned myeloma experts covering a broad range of topics, including treatment advances, novel therapies, supportive care, and clinical trials.

The seminars are held four times a year across the country to expand the IMF’s programs’ reach to a wider audience. The IMF works closely with local support groups to promote these meetings, and attendance general ranges from 150-250 people.

“The data gathered from the interactive sessions provide invaluable information on treatment trends, why patients choose one treatment over another, patients’ opinions on certain clinical trials, most common side effects, as well as other important information that helps physicians better serve myeloma patients,” said Dr. Durie.

Additional Details
What: IMF Patient & Family Seminar (PFS)
When: Friday, October 10 2014 and Saturday, October 11 2014
Where: Hilton Short Hills (41 JFK Parkway, Short Hills, NJ 07078)

List of Participants
Dr. Brian Durie, The IMF and Cedars Sinai, Los Angeles, CA
Dr. David Vesole, John Theurer Cancer Ctr, Hackensack, NJ
Dr. Ruben Niesvizky, Weill Cornell Medical College, New York, NY
Dr. Suzanne Lentzsch, Columbia University, New York, NY
Dr. Robert Kyle, Mayo Clinic, Rochester, MN
Mr. Mike Katz, Myeloma Patient, & IMF Board of Directors member
Naveen Bangia, PhD, Director of Scientific Affairs, Binding Site
Ann Mc Neill, RN, MSN, APN, OCN, IMF NLB Associate Member

About Myeloma
Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affects production of red cells, white cells and stem cells and can damage bone. It is growing in numbers and affecting increasingly younger people.
About the International Myeloma Foundation.

Celebrating its 23rd anniversary, the International Myeloma Foundation reaches more than 350,000 members in 120 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses on four key areas: research, education, support, and advocacy.

To date, the IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned hotline, and established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. The IMF can be reached at (800) 452-CURE (2873) or visit the global website. For more information about the Black Swan Research, click here.